Skip to main content

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Crame.

Yesterday, March 4, 2015, 133 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $62.50 to $191,397,755.25.

Highlighted Stocks Traded by Insiders:

Bright Horizons Family Solutions (BFAM) - FREE Research Report

Tocio Mary Ann, who is President and COO at Bright Horizons Family Solutions, sold 25,000 shares at $50.07 on March 4, 2015. Following this transaction, the President and COO owned 180,566 shares meaning that the stake was reduced by 12.16% with the 25,000-share transaction.

The shares most recently traded at $50.42, up $0.35, or 0.69% since the insider transaction. Historical insider transactions for Bright Horizons Family Solutions go as follows:

  • 4-Week # shares bought: 1,400
  • 4-Week # shares sold: 8,014
  • 12-Week # shares bought: 1,400
  • 12-Week # shares sold: 8,014
  • 24-Week # shares bought: 1,400
  • 24-Week # shares sold: 58,214

The average volume for Bright Horizons Family Solutions has been 173,000 shares per day over the past 30 days. Bright Horizons Family Solutions has a market cap of $3.1 billion and is part of the services sector and diversified services industry. Shares are up 6.68% year-to-date as of the close of trading on Wednesday.

Bright Horizons Family Solutions Inc. provides child care and early education, and other services for employers and families. It operates through three segments: Full-Service Center-Based Child Care, Back-Up Dependent Care, and Other Educational Advisory Services. The company has a P/E ratio of 46.7. Currently, there are 6 analysts who rate Bright Horizons Family Solutions a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BFAM - FREE

TheStreet Quant Ratings

Scroll to Continue

TheStreet Recommends

rates Bright Horizons Family Solutions as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, solid stock price performance, good cash flow from operations and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Bright Horizons Family Solutions Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Brandywine Realty (BDN) - FREE Research Report

Devuono H Jeffrey, who is Executive Vice President at Brandywine Realty, sold 50,000 shares at $15.86 on March 4, 2015. Following this transaction, the Executive Vice President owned 144,221 shares meaning that the stake was reduced by 25.74% with the 50,000-share transaction.

The shares most recently traded at $15.70, down $0.16, or 1.02% since the insider transaction. Historical insider transactions for Brandywine Realty go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 70,000
  • 24-Week # shares sold: 70,000

The average volume for Brandywine Realty has been 1.5 million shares per day over the past 30 days. Brandywine Realty has a market cap of $2.8 billion and is part of the financial sector and real estate industry. Shares are down 1.88% year-to-date as of the close of trading on Wednesday.

Brandywine Realty Trust is a publically owned real estate investment trust. The firm invests in real estate markets of the United States. It makes investments in office, mixed-use, and industrial properties. The stock currently has a dividend yield of 3.79%. Currently, there are 8 analysts who rate Brandywine Realty a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BDN - FREE

TheStreet Quant Ratings

rates Brandywine Realty as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full

Brandywine Realty Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

SurModics (SRDX) - FREE Research Report

Stich Joseph J., who is VP, Bus Ops & GM, IVD at SurModics, sold 1,000 shares at $24.41 on March 4, 2015. Following this transaction, the VP, Bus Ops & GM, IVD owned 24,144 shares meaning that the stake was reduced by 3.98% with the 1,000-share transaction.

The shares most recently traded at $24.78, up $0.37, or 1.51% since the insider transaction. Historical insider transactions for SurModics go as follows:

  • 4-Week # shares bought: 1,500
  • 4-Week # shares sold: 5,083
  • 12-Week # shares bought: 1,500
  • 12-Week # shares sold: 5,083
  • 24-Week # shares bought: 1,500
  • 24-Week # shares sold: 6,083

The average volume for SurModics has been 66,500 shares per day over the past 30 days. SurModics has a market cap of $315.5 million and is part of the health care sector and drugs industry. Shares are up 10.14% year-to-date as of the close of trading on Wednesday.

SurModics, Inc. provides surface modification and in vitro diagnostic technologies to the healthcare industry. The company operates through two segments, Medical Device and In Vitro Diagnostics. The company has a P/E ratio of 27.4. Currently, there are 3 analysts who rate SurModics a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SRDX - FREE

TheStreet Quant Ratings

rates SurModics as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

SurModics Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null